TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients

por Dold, L., Zimmer, L., Schwarze-Zander, C., Boesecke, C., Mohr, R., Wasmuth, J.-C., Ommer, K., Gathof, B., Krämer, B., Nattermann, J., Strassburg, C. P., Rockstroh, J. K., Spengler, U., Langhans, B.
Publicado 2020